A COMPARATIVE CLINICAL TRIAL TO EVALUATE THE EFFICACY OF LAUHADI CHURNA AND KASISA BHASMA IN THE MANAGEMENT OF PANDU WITH SPECIAL REFERENCE TO IRON DEFICIENCY ANAEMIA

A RANDOMIZED COMPARATIVE CLINICAL TRIAL TO EVALUATE THE EFFICACY OF LAUHADI CHURNA AND KASISA BHASMA IN THE MANAGEMENT OF PANDU WITH SPECIAL REFERENCE TO IRON DEFICIENCY ANAEMIA - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075207

Enrollment

Registered

2024-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of either sex with age above 18 years to 60 years 2 Patient present with classical sign and symptoms of Pandu 3 Patient present with sign and symptoms of iron deficiency anaemia 4 Patient having Hb in the range of 7-10 gm/dl 5 Serum iron content less then 50ug /L 6 TIBC in the range of more than 350ug/dl 7 Microcytic hypochromic anaemia i.e. MCHC less then 34 gm per dl and MCV less then 80 fL 8 Only those patients having Pandu as an independent disease & not as upadrava 9 Patient willing to give informed consent to participate in trial

Exclusion criteria

Exclusion criteria: 1. Patient with severe Anaemia or congenital anaemia. 2. Patient present with co- morbid disorder (D.M, T.B, R.A etc.) 3. Patient with poorly controlled hypertension. 4. Patient with concurrent serious hepatic disorders or renal disorders or any other systemic / serious complication like cerebrovascular / cardiovascular disease that may jeopardize the study. 5. H/o Hypersensitivity to the trial drug or any of its ingredients. 6. Patient had completed participation in any other clinical trial in past 6 months. 7. Pregnant or lactating women. 8. Patients having Kamla, Rakta-Pradara, Rakta-Pitta, Raktarsha, Raktasrava 9. Age below 18 years 10. SGOT level more than 40 unit/lit. 11. SGPT level more than 6 unit/lit. 12. S.creatinine level more than 1.5 mg/dl . 13. S.Urea level more than 30 mg/dl

Design outcomes

Primary

Measure	Time frame
Reduction in Sign and Symptoms of Pandu with in 12 weeksTimepoint: Reduction in Sign and Symptoms of Pandu with in 12 weeks	—

Secondary

Measure	Time frame
1 To Observe adverse adverse effects if any 2 Cost effective treatmentTimepoint: 75 Days	—

Countries

India

Contacts

Public ContactDr ANAND PRATAP SINGH

Kunwar Shekhar Vijendra Ayurved Medical College And Research Centre

apsingh11264@gmail.com8840749954

Outcome results